FAQ

If your industry is healthcare and specifically the life sciences, yes. Our Advisors are considered life science subject matter experts (SME). Categories include: on-demand market research, medical device, pharmaceutical, biotech, digital health, and others.

Yes. We believe that for a client and their associated goals to be attained, there must be an open channel of communications between all stakeholders.

We’re advocates of open and transparent dialogue with clients, and typically use daily correspondence (ex: zoom mtgs, phone calls, face-to-face mtgs, etc.) so that we may collectively support and advance agreed objectives.

Our market research capability has been strengthened by the addition of two new, specialized research services:

  • GTM Sprint: For rapid, focused insights to accelerate decision-making.
  • GTM Crossroads: For in-depth analysis at critical strategic junctures.

Comprehensive overviews of both services are now available under the ‘On-Demand Market Research’ tab.”

This is a bit of a trick question, as success is never guaranteed, but certainly expected. We work with clients to build a sustainable commercial platform that is expected to accelerate all sales and marketing efforts. Imagined results…expanded distribution channels in the US, increased revenues, and elevated brand architecture and equity.

We act as a strategic partner to your sales team, enhancing their planning, effectiveness, and outcomes. While we do not sell on your behalf, our Commercialization Services allow us to directly support your team in key client interactions – including sales calls, presentations, and negotiations – to bolster their efforts and improve client retention.

As a rule, no. If a competitor does not sell in the same region of the US, there is no overlap in product functionality or distribution, and we ‘re able to get the permission of existing clients, exceptions can be made.

This obviously only applies to our Advisory and Commercialization Services.

Yes. One of our primary objectives is to help small or emerging life science companies expand their reach to include the US. At the time this site was published, we have ongoing discussions with innovative healthcare firms in the England, Scotland, China, potentially Thailand and of course throughout the US.

Yes, specifically for our Advisory and Commercialization Services.

There’s a couple of ways to get started. First, review our website to get a brief overview of each available service. Second (and most in-depth), schedule an appointment via Calendly under the Contact section of our website. An appointment will allow for more personalized explanations of individual questions.